Keyphrases
Heart Failure
100%
Diabetes
100%
Chronic Heart Failure
100%
Diabetic
80%
Heart Failure Patients
60%
New Drugs
40%
Non-diabetic
40%
Type 1 Diabetes Mellitus (T1DM)
40%
Renin-angiotensin System Inhibitors
40%
Target Dose
40%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
40%
Left Ventricular Ejection Fraction
20%
Dutch
20%
No Significant Difference
20%
Comorbidity
20%
Potential Impact
20%
Without Diabetes
20%
High Prevalence
20%
Estimated Glomerular Filtration Rate
20%
Large Cohort
20%
Heart Failure Treatment
20%
Beta-blockers
20%
Patients with Chronic Heart Failure
20%
Renal Function
20%
Mineralocorticoid Receptor Antagonists
20%
Heart Failure Therapy
20%
Patients with Diabetes
20%
Total Population
20%
European Data
20%
Drug Class
20%
Prohormone
20%
Diabetes Mellitus Treatment
20%
Prevalence of Diabetes Mellitus
20%
Diabetes Distress
20%
Sodium-glucose Cotransporter
20%
Heart Failure Clinic
20%
On-state Current
20%
Heart Failure Medication
20%
INIS
populations
100%
heart failure
100%
patients
57%
diabetes mellitus
28%
glucose
21%
drugs
21%
sodium
21%
doses
14%
guidelines
14%
enrichment
14%
angiotensin
14%
renin
14%
data
7%
therapy
7%
receptors
7%
comparative evaluations
7%
males
7%
morbidity
7%
kidneys
7%
filtration
7%
mineralocorticoids
7%
Medicine and Dentistry
Diabetes
100%
Congestive Heart Failure
100%
Diabetes Mellitus
78%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Renin-Angiotensin System Inhibitor
14%
Prevalence
7%
Beta Adrenergic Receptor Blocking Agent
7%
Heart Left Ventricle Ejection Fraction
7%
Glomerular Filtration Rate
7%
Outpatient
7%
Kidney Function
7%
Brain Natriuretic Peptide
7%
Amino Terminal Sequence
7%
Mineralocorticoid Antagonist
7%
Hormone Precursor
7%
Sodium Glucose Cotransporter 2
7%
Comorbidity
7%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Diabetes Mellitus
78%
Renin-Angiotensin System Inhibitor
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Prevalence
7%
Brain Natriuretic Peptide
7%
Beta Adrenergic Receptor Blocking Agent
7%
Mineralocorticoid Antagonist
7%
Hormone Precursor
7%
Sodium Glucose Cotransporter 2
7%
Comorbidity
7%